Form 4 · Filed Mar 3, 2026, 12:00 PM UTC
TRDA/Entrada Therapeutics, Inc.
Sethuraman Natarajan — President, Research & Develop.
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | F | other | 7,577 | $12 | $89,078 | 242,224 |
| Mar 2, 2026 | F | other | 3,898 | $12 | $45,442 | 249,801 |
| Mar 1, 2026 | A | other | 55,800 | $0 | — | 253,699 |
| Mar 1, 2026 | A | other | 83,200 | $0 | — | 83,200 |
Source: SEC EDGAR raw filing ↗ · Accession 0001873394-26-000001